Review on Renal cell carcinoma with t(X;1)(p11;p34) SFPQ/TFE3, with data on clinics, and the genes involved. Keywords Renal cell carcinoma; chromosome X; chromosome 1; SFPQ; TFE3; MiT family
Identity
Must not be confused with the t(X;1)(p11.2;q21), also found in renal cell carcinoma.
Classification
Xp11 translocation renal cell carcinoma (RCCs) harbor gene fusions involving TFE3 transcription factor. The t(6;11) RCCs harbor a specific MALAT1 (Alpha) -TFEB gene fusion. TFEB and TFE3 belong to the same MiT subfamily of transcription factors. Because of similarities at the clinical, morphologic, immunohistochemical, and genetic levels, the Xp11 translocation RCCs and t(6;11) RCCs are currently grouped together under the category of MiT family translocation renal cell carcinoma. 
Clinics and pathology

Phenotype / cell stem origin
The identical gene fusion may be found in Xp11 translocation PEComas and Melanotic Xp11 translocation cancers, which differ from the RCC in that they are PAX8 negative and Cathepsin K positive by immunohistochemistry. 
Genes involved and proteins
TFE3 (transcription factor E3)
Protein
Contains a transcriptional activation domain , a helix-loop-helix, and a leucine zipper; member of the basic helix-loop-helix family (b-HLH) of transcription factors. 
SFPQ (PTB-associated splicing factor)
Result of the chromosomal anomaly
Hybrid Gene
Description 5' SFPQ -3' TFE3
Fusion Protein
Description N-term SFPQ and most of it fused to the DNA binding domains of TFE3 (excluding the acidic transcriptional activation domain, including the Cterm helix-loop-helix, and the leucine zipper); no TFE3-SFPQ reciprocal transcript, as the der(X) t(X;1) is missing; the normal TFE3 transcript is found.
